投稿信息
投稿信息
員@2x.png)
審稿費(fèi)用
暫無數(shù)據(jù)
版面費(fèi)用
暫無數(shù)據(jù)
中國人發(fā)表比例
2023年中國人文章占該期刊總數(shù)量暫無數(shù)據(jù) (2022年為100.00%)
自引率
9.1 %
年文章數(shù)
2508
期刊官網(wǎng)
點(diǎn)擊查看
(點(diǎn)擊次數(shù):19598)
投稿鏈接
點(diǎn)擊查看
(點(diǎn)擊次數(shù):8097次)
作者需知
點(diǎn)擊查看
(點(diǎn)擊次數(shù):773次)
NCBI查詢
期刊簡介
稿件收錄要求
稿件收錄要求
This journal aims to provide a forum for publication of clinical and experimental pharmacology studies related to diabetes, obesity and metabolism, including evaluations of new glucose and weight-lowering drugs, new therapeutic developments in the management and prevention of diabetic complications, e.g. growth factors and biotechnology products for foot ulcers, and clinical trials involving established medicines, e.g. optimal treatment of hypertension, lipids or infection in the diabetic population.
常用鏈接
期刊論壇
|
中國SCI論文
|
期刊介紹
|
投稿信息
|
雜志官網(wǎng)
|
投稿鏈接
|
作者需知
|
PMC鏈接
|
Pubmed全文檢索
